Holen Sie sich die Stockscreener-App
0.9174
0.00%
0.00
Schlusskurs vom Vortag:
$0.9174
Offen:
$0.9
24-Stunden-Volumen:
31,665
Relative Volume:
0.32
Marktkapitalisierung:
$6.04M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-1.13M
KGV:
-1.9983
EPS:
-0.4591
Netto-Cashflow:
$-4.60M
1W Leistung:
-6.67%
1M Leistung:
-11.79%
6M Leistung:
-24.18%
1J Leistung:
-47.28%
1-Tages-Spanne:
$0.8827
$0.9174
1-Wochen-Bereich:
$0.8827
$1.001
52-Wochen-Spanne:
$0.80
$1.94
Pharmacyte Biotech Inc Stock (PMCB) Company Profile
Firmenname
Pharmacyte Biotech Inc
Sektor
Branche
Telefon
(917) 595.2850
Adresse
3960 HOWARD HUGHES PARKWAY, LAS VEGAS
Vergleichen Sie PMCB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 2.24 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
2.50 | 4.21B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.00 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
5.02 | 217.47M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.2265 | 502.27M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.3695 | 0 | 0 | 0 | 0 | 0.00 |
Pharmacyte Biotech Inc Aktie (PMCB) Neueste Nachrichten
What Fibonacci levels say about PharmaCyte Biotech Inc. reboundWeekly Trade Summary & Growth Oriented Trading Recommendations - newser.com
Can PharmaCyte Biotech Inc. recover in the next quarter2025 Top Gainers & Fast Entry Momentum Alerts - newser.com
Will PharmaCyte Biotech Inc. stock reach all time highs in 2025Market Volume Summary & Safe Capital Growth Tips - newser.com
What sentiment indicators say about PharmaCyte Biotech Inc. stockQuarterly Profit Review & Technical Pattern Based Signals - newser.com
Can PharmaCyte Biotech Inc. stock hit record highs againGap Down & Low Drawdown Momentum Ideas - newser.com
How PharmaCyte Biotech Inc. stock performs in stagflationEntry Point & Consistent Growth Equity Picks - newser.com
Combining machine learning predictions for PharmaCyte Biotech Inc.Portfolio Update Report & Weekly High Potential Stock Alerts - newser.com
Developing predictive dashboards with PharmaCyte Biotech Inc. dataJuly 2025 WrapUp & Verified Chart Pattern Trade Signals - newser.com
PharmaCyte Biotech Amends Equity Incentive Plan - TipRanks
PMCB shareholders approve Nasdaq 5635(d) issuance and plan increase - Stock Titan
Statistical indicators supporting PharmaCyte Biotech Inc.’s strengthTrend Reversal & Free Safe Capital Growth Stock Tips - newser.com
Top chart patterns to watch in PharmaCyte Biotech Inc.2025 Trading Recap & Long Hold Capital Preservation Tips - newser.com
Applying chart zones and confluence areas to PharmaCyte Biotech Inc.Gap Up & Stepwise Trade Execution Plans - newser.com
What indicators show strength in PharmaCyte Biotech Inc.Product Launch & Fast Exit and Entry Strategy Plans - newser.com
Is PharmaCyte Biotech Inc. forming a bottoming baseMarket Growth Summary & Capital Protection Trading Alerts - newser.com
What to do if you’re stuck in PharmaCyte Biotech Inc.Bond Market & Weekly Return Optimization Alerts - newser.com
How PharmaCyte Biotech Inc. stock benefits from global expansionJuly 2025 Summary & Low Risk Growth Stock Ideas - Fundação Cultural do Pará
Is PharmaCyte Biotech Inc. stock attractive for passive investors2025 Top Decliners & Expert Approved Trade Ideas - newser.com
Finanzdaten der Pharmacyte Biotech Inc-Aktie (PMCB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.13%
0.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):